Drug survival of adalimumab and infliximab in hidradenitis suppurativa patients: a daily practice cohort study

被引：0
|
作者：
Prens, Lisette M. [1 ]
Bouwman, Klasiena [1 ]
Aarts, Pim [2 ]
Arends, Suzanne [3 ]
van Straalen, Kelsey R. [2 ]
Dudink, Koen [2 ]
van der Zee, Hessel H. [2 ]
Prens, Errol P. [2 ]
Horvath, Barbara [1 ]
机构：
[1] Univ Med Ctr Groningen, Dermatol, Groningen, Netherlands
[2] Univ Med Ctr Rotterdam, Dermatol, Rotterdam, Netherlands
[3] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
50
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [31] Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa
    Garbayo-Salmons, Patricia
    Vilarrasa, Eva
    Bassas-Vila, Julio
    Mora-Fernandez, Veronica
    Fuertes, Irene
    Luque-Luna, Mar
    Fornons-Servent, Rosa
    Martin-Ezquerra, Gemma
    Aguayo-Ortiz, Rafael Sergio
    Ceravalls, Joan
    Mollet, Jordi
    Tomas, Alvaro Gomez
    Masferrer, Emili
    Corral-Magana, Oriol
    Matas-Nadal, Clara
    del Estal, Jorge
    Bailon, Diana Fuertes
    Calvet, Joan
    Romani, Jorge
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [32] Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series
    Tasnim Abdalla
    Mark Mansour
    Dorra Bouazzi
    Michelle A. Lowes
    Gregor B. E. Jemec
    Afsaneh Alavi
    American Journal of Clinical Dermatology, 2021, 22 : 275 - 283
  • [33] Predictive factors associated with response to adalimumab in patients with hidradenitis suppurativa
    Caro, Raffaele Dante Caposiena
    Sechi, Andrea
    Venturini, Marina
    Molinelli, Elisa
    Bisigotti, Valerio
    Tartaglia, Chiara
    Raone, Beatrice
    Patrizi, Annalisa
    Calavara-Pinton, Piergacomo
    Offidani, Annamaria
    Bianchi, Luca
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 55 - 55
  • [34] Response to adalimumab in Caucasian and Asian patients with hidradenitis suppurativa: A retrospective cohort study of an Australian cohort stratified by patient-reported ethnicity
    Pham, James
    Flora, Akshay
    Guttman, Lauren
    Allan, Timothy
    Chandran, Nisha Suyien
    Frew, John W.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024,
  • [35] Predictive biomarkers of response to adalimumab treatment in patients with hidradenitis suppurativa
    Sengl, Michael
    Lehner, Lea Sophia
    Hohlfeld, Ralf
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (04) : e160 - e160
  • [36] RESIDUAL BURDEN IN ADALIMUMAB-TREATED PATIENTS WITH HIDRADENITIS SUPPURATIVA
    Kimball, A. B.
    Tran, T.
    Friesen, D.
    Shang, A.
    Pansar, I
    Oh, T.
    Aleshin, M. A.
    VALUE IN HEALTH, 2024, 27 (06) : S131 - S131
  • [37] Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series
    Abdalla, Tasnim
    Mansour, Mark
    Bouazzi, Dorra
    Lowes, Michelle A.
    Jemec, Gregor B. E.
    Alavi, Afsaneh
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (02) : 275 - 283
  • [38] Predictive biomarkers of response to adalimumab therapy in patients with hidradenitis suppurativa
    Chen, Zhenhua
    Wei, Qinhua
    Tang, Gao
    Shi, Hongsheng
    Qin, Laishun
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (04) : e171 - e171
  • [39] Adalimumab long-term treatment in hidradenitis suppurativa patients
    Rosi, Elia
    Di Cesare, Antonella
    Fastame, Maria T.
    Scandagli, Ilaria
    Silvi, Gianmarco
    Prignano, Francesca
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 104 - 104
  • [40] Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa
    Cao, Yonghao
    Hong, Feng
    Conlon, Donna
    Sidur, Lauren
    Smith, Kathleen
    Fang, Yuni
    Cuff, Carolyn
    Kaymakcalan, Zehra
    Ruzek, Melanie
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 24 - 24
12345